Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Tumor-prone phenotype of the DDB2-deficient mice

Abstract

DDB2 is an essential subunit of the damaged-DNA recognition factor DDB, which is involved in global genomic repair in human cells. Moreover, DDB2 is mutated in the repair-deficiency disease xeroderma pigmentosum (Group E). Expression of DDB2 in human cells is induced by P53, BRCA1 and by ionizing radiation. The DDB2 protein associates with transcriptional activator and coactivator proteins. In addition, DDB2 in conjunction with DDB1 associates with cullin 4A and the Cop9/signalosome. We generated a mouse strain deficient for DDB2 (DDB2−/−). Consistent with the human disease (XP-E), the DDB2−/− mice were susceptible to UV-induced skin carcinogenesis. We observed a significant difference in the initial rate of cyclobutane pyrimidine dimer (CPD)-removal from the skin following UV irradiation. Also, the DDB2-deficient mice exhibited a significantly reduced life span compared to their wild-type littermates. Moreover, unlike other XP-deficient mice, the DDB2-deficient mice developed spontaneous malignant tumors at a high rate between the ages of 20 and 25 months. The observations suggest that, in addition to DNA repair, the other interactions of DDB2 are significant in its tumor suppression function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Abramic M, Levine AS and Protic M . (1991). J. Biol. Chem., 266, 22439–22500.

  • Chen X, Zhang Y, Douglas L and Zhou P . (2001). J. Biol. Chem., 276, 48175–48182.

  • Chu G and Chang E . (1988). Science, 242, 564–567.

  • Cleaver JE, Thompson LH, Richardson AS and States JC . (1999). Hum. Mutat., 14, 9–22.

  • Datta A, Bagchi S, Nag A, Shiyanov P, Adami GR, Yoon T and Raychaudhuri P . (2001). Mutat. Res., 486, 89–97.

  • de Vries A, van Oostrom CThM, Hofhuls FMA, Dortant PM, Berg RJW, de Gruiji FR, Wester PW, van Kreiji CF, Capel PJA, van Steeg H and Verbeek SJ . (1995). Nature, 377, 169–173.

  • Friedberg EC, Walker GC and Siede W . (1995). DNA Repair and Mutagenesis. ASM Press: Washington DC.

    Google Scholar 

  • Fujiwara Y, Masutani C, Mizukoshi T, Kondo J, Hanaoka F and Iwai S . (1999). J. Biol. Chem., 274, 20027–20033.

  • Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, Tanaka K and Nakatani Y . (2003). Cell, 113, 357–367.

  • Hayes S, Shiyanov P, Chen X and Raychaudhuri P . (1998). Mol. Cell Biol., 18, 240–249.

  • Hartman AR and Ford JM . (2002). Nat. Genet., 32, 180–184.

  • Hwang BJ and Chu G . (1993). Biochemistry, 32, 1657–1666.

  • Hwang BJ, Toering S, Francke U and Chu G . (1998a). Mol. Cell Biol., 18, 4391–4399.

  • Hwang BJ, Ford JM, Hanawalt PC and Chu G . (1998b). Proc. Natl. Acad. Sci. USA, 96, 424–428.

  • Inoki T, Yamagami S, Inoki Y, Tsuru T, Hamamoto T, Kagawa Y, Mori T and Endo H . (2004). Biochem. Biophys. Res. Commun., 314, 1036–1043.

  • Iwao K, Kawasaki H, Taira H and Yokoyama KK . (1999). Nucl. Acid. Symp. Ser., 42, 207–208.

  • Itoh T, Linn S, Ono T and Yamaizumi M . (2000). J. Invest. Dermatol., 114, 1022–1029.

  • Itoh T, O'Shea C and Linn S . (2003). Mol. Cell Biol., 23, 7540–7553.

  • Itoh T, Cado D, Kamide R and Linn S . (2004). Proc. Natl. Acad. Sci. USA, 101, 2052–2057.

  • Kazantsev A, Mu D, Nichols AF, Zhao X, Linn S and Sancar A . (1996). Proc. Natl. Acad. Sci. USA, 93, 5014–5018.

  • Keeney S, Chang GJ and Linn S . (1993). J. Biol. Chem., 268, 21293–21300.

  • Lee T-H, Elledge SJ and Butel JS . (1995). J. Virol., 69, 1107–1114.

  • Lin GY and Lamb RA . (2000). J. Virol., 74, 9152–9166.

  • Lu Y-P, Lou Y-R, Yen P, Mitchel D, Huang M-T and Conney AH . (1999). Cancer Res., 59, 4591–4602.

  • Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, Kundu TK, Chait BT and Roeder RG . (2001). Mol. Cell Biol., 20, 6782–6795.

  • Nag A, Bondar T, Shiv S and Raychaudhuri P . (2001a). Mol. Cell Biol., 21, 6738–6747.

  • Nag A, Datta A, Yoo K, Bhattacharyya D, Chakrabortty A, Wang X, Slagle B, Costa R and Raychaudhuri P . (2001b). J. Virol., 75, 10383–10392.

  • Nakane H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, Murai H, Nakatsuru Y, Ishikawa T, Hirota S, Kitamura Y, Kato Y, Tsunoda Y, Miyauchi H, Horio T, Tokunaga T, Matsunaga T, Nikaido O, Nishimune Y, Okada Y and Tanaka K . (1995). Nature, 377, 165–168.

  • Nichols AF, Ong P and Linn S . (1996). J. Biol. Chem., 271, 24317–24320.

  • Nichols AF, Itoh T, Graham JA, Liu W, Yamaizumi M and Linn S . (2000). J. Biol. Chem., 275, 21422–21428.

  • Reardon JT, Nichols AF, Keeney S, Smith CA, Taylor JS, Linn S and Sancar A . (1993). J. Biol. Chem., 268, 21301–21308.

  • Sancar A . (1996). Annu. Rev. Biochem., 65, 43–81.

  • Sands AT, Abulin A, Sanchez A, Conti CJ and Bradley A . (1995). Nature, 377, 162–165.

  • Shiyanov P, Nag A and Raychaudhuri P . (1999). J. Biol. Chem., 274, 35309–35312.

  • Takimoto R, Maclachlan TK, Dicker DT, Niitsu Y, Mori T and El-Deiry WS . (2002). Cancer Biol. Ther., 1, 177–186.

  • Tang JY, Hwang BJ, Ford JM, Hanawalt PC and Chu G . (2000). Mol. Cell, 5, 737–744.

  • Tini M, Benecke A, Um SJ, Torchia J, Evans RM and Chambon P . (2002). Mol. Cell, 9, 265–277.

  • Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT and Mulligan RC . (1991). Cell, 65, 1153–1163.

  • Ulane CM and Horvath CM . (2002). Virology, 304, 160–166.

  • Wakasugi M, Kawashima A, Morioka H, Linn S, Sancar A, Mori T, Nikaido O and Matsunaga T . (2002). J. Biol. Chem., 277, 1637–1640.

  • Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ and Dixit VM . (2004). Science, 303, 1371–1374.

  • Wijnhoven SW, Kool HJ, Mullenders LH, van Zeeland AA, Friedberg EC, van der Horst GT, van Steeg H and Vrieling H . (2000). Oncogene, 19, 5034–5037.

  • Zolezzi F and Linn S . (2000). Gene, 245, 151–159.

Download references

Acknowledgements

We thank Dr S Linn (UC, Berkeley) for helping us with reagents. We thank the UIC Transgenic Facility for blastocyst injections. HK is supported by a grant from the NCI (1R01CA100204) and a grant from the DOD (DAMD 17-02-1-0413). This work was supported by grants from the NCI (CA 77637 and CA 88863) to PR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pradip Raychaudhuri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoon, T., Chakrabortty, A., Franks, R. et al. Tumor-prone phenotype of the DDB2-deficient mice. Oncogene 24, 469–478 (2005). https://doi.org/10.1038/sj.onc.1208211

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208211

Keywords

This article is cited by

Search

Quick links